Literature DB >> 18354076

Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

Kultigin Turkmen1, Huseyin Oflaz, Bora Uslu, Arif O Cimen, Ali Elitok, Erdem Kasikcioglu, Sabahat Alisir, Fatih Tufan, Sule Namli, Mukremin Uysal, Tevfik Ecder.   

Abstract

BACKGROUND AND OBJECTIVES: Cardiovascular problems are a major cause of morbidity and mortality in patients with autosomal dominant polycystic kidney disease. Endothelial dysfunction, an early and reversible feature in the pathogenesis of atherosclerosis, is associated with increased vascular smooth muscle tone, arterial stiffening, and increased intima-media thickness. Coronary flow velocity reserve is a noninvasive test showing endothelial function of epicardial coronary arteries and coronary microcirculatory function. The aim of the study was to investigate the carotid intima-media thickness and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Thirty normotensive patients with autosomal dominant polycystic kidney disease (10 male, 20 female) with well-preserved renal function and 30 healthy subjects (12 male, 18 female) were included in the study. Coronary flow velocity reserve was measured at baseline and after dipyridamole infusion by echocardiography. Coronary flow velocity reserve was calculated as the ratio of hyperemic to baseline diastolic peak velocities.
RESULTS: Carotid intima-media thickness was significantly higher in patients than in control subjects (0.80 +/- 0.29 versus 0.54 +/- 0.14 mm, respectively; P < 0.001). Moreover, coronary flow velocity reserve was significantly lower in patients than in control subjects (1.84 +/- 0.39 versus 2.65 +/- 0.68, respectively; P < 0.001).
CONCLUSIONS: Normotensive patients with autosomal dominant polycystic kidney disease with well-preserved renal function have significantly increased carotid intima-media thickness and significantly decreased coronary flow velocity reserve compared with healthy subjects. These findings suggest that atherosclerosis starts at an early stage in the course of their disease in patients with autosomal dominant polycystic kidney disease.

Entities:  

Mesh:

Year:  2008        PMID: 18354076      PMCID: PMC2440264          DOI: 10.2215/CJN.02330607

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  40 in total

Review 1.  Angiotensin II: a pivotal factor in the progression of renal diseases.

Authors:  G Wolf
Journal:  Nephrol Dial Transplant       Date:  1999       Impact factor: 5.992

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

4.  Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.

Authors:  W L Henry; A DeMaria; R Gramiak; D L King; J A Kisslo; R L Popp; D J Sahn; N B Schiller; A Tajik; L E Teichholz; A E Weyman
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

5.  Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease.

Authors:  Huseyin Oflaz; Sabahat Alisir; Banu Buyukaydin; Orhan Kocaman; Faruk Turgut; Sule Namli; Burak Pamukcu; Aytac Oncul; Tevfik Ecder
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

6.  Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X.

Authors:  Leonarda Galiuto; Alfonso Sestito; Sabrina Barchetta; Gregory A Sgueglia; Fabio Infusino; Claudio La Rosa; Gaetano Lanza; Filippo Crea
Journal:  Am J Cardiol       Date:  2007-03-28       Impact factor: 2.778

7.  Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.

Authors:  A Bardají; A M Vea; C Gutierrez; C Ridao; C Richart; J A Oliver
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

8.  Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.

Authors:  Fumihiko Kamezaki; Hiromi Tasaki; Kazuhito Yamashita; Kiyoko Shibata; Noriko Hirakawa; Masato Tsutsui; Ryouji Kouzuma; Toshihisa Nagatomo; Tetsuo Adachi; Yutaka Otsuji
Journal:  Hypertens Res       Date:  2007-08       Impact factor: 3.872

9.  Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy.

Authors:  Emmanuel I Skalidis; Frangiskos I Parthenakis; Alexandros P Patrianakos; Michael I Hamilos; Panos E Vardas
Journal:  J Am Coll Cardiol       Date:  2004-11-16       Impact factor: 24.094

Review 10.  Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool.

Authors:  Fausto Rigo
Journal:  Cardiovasc Ultrasound       Date:  2005-03-25       Impact factor: 2.062

View more
  18 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

3.  Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.

Authors:  Cuma Bulent Gul; Abdulmecit Yildiz; Alparslan Ersoy; Serdar Kahvecioglu; Burak Asiltas; Fatih Yildirim; Selime Ermurat; Saim Sag; Aysegul Oruc; Sumeyye Gullulu; Mustafa Gullulu
Journal:  Int Urol Nephrol       Date:  2015-06-06       Impact factor: 2.370

Review 4.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

5.  Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.

Authors:  Godela M Brosnahan; Kaleab Z Abebe; Frederic F Rahbari-Oskoui; Charity G Patterson; Kyongtae T Bae; Robert W Schrier; William E Braun; Arlene B Chapman; Michael F Flessner; Peter C Harris; Ronald D Perrone; Theodore I Steinman; Vicente E Torres
Journal:  Curr Hypertens Rev       Date:  2017

Review 6.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

7.  Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Authors:  Imed Helal; Kim McFann; Berenice Reed; Xiang-Dong Yan; Robert W Schrier; Godela M Fick-Brosnahan
Journal:  Nephrol Dial Transplant       Date:  2012-12-04       Impact factor: 5.992

Review 8.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

9.  Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.

Authors:  Vasiliki Karava; Cherine Benzouid; Julien Hogan; Claire Dossier; André Pierre Denjean; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

10.  Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?

Authors:  Asmin Andries; Kristien Daenen; François Jouret; Bert Bammens; Djalila Mekahli; Ann Van Schepdael
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.